ADC Therapeutics SA (ADCT) Announces Board Changes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Stifel sees AI supply constraints ahead of Q3 tech earnings
ADC Therapeutics Announces Evolution of Board of Directors
June 15, 2023 7:15 AM EDTStrengthens the Board with the election of Robert W. Azelby as director
Board will be comprised of nine directors; gratitude expressed for contributions of outgoing directors
LAUSANNE, Switzerland, June 15, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced the election of Robert W. Azelby to its Board of Directors. Mr. Azelby brings more than 30 years of biopharmaceutical leadership and commercial experience to ADC Therapeutics Board.
Were delighted to welcome Bob to our Board. He brings with him... More



